Assays that measure RSV-specific neutralizing antibody activity are very useful for evaluating vaccine candidates, performing seroprevalence studies, and detecting infection. Neutralizing antibody activity is normally measured by a plaque reduction neutralization assay or by a microneutralization assay with or without complement. These assays measure the functional capacity of serum (or other fluids) to neutralize virus infectivity in cells as compared to ELISA assays that only measure the binding capacity against an antigen. This chapter discusses important elements in standardization of the RSV-specific microneutralization assay for use in the laboratory.
CITATION STYLE
Piedra, P. A., Hause, A. M., & Aideyan, L. (2016). Respiratory syncytial virus (RSV): Neutralizing antibody, a correlate of immune protection. In Methods in Molecular Biology (Vol. 1442, pp. 77–91). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3687-8_7
Mendeley helps you to discover research relevant for your work.